MetaVia Inc. (MTVA) - Kapitalizatsiyaning foydaga nisbati
MetaVia Inc (MTVA) istiqbollari yangi dori vositalari sinovlarining uzoq muddatli ishga tushirilishiga bog'liq, klinikadan oldingi bosqichning spekulyativ salohiyati esa allaqachon narxga kiritilgan. MetaVia Inc (MTVA) neyronlar yemirilishiga qarshi kurashish usullarining yetakchi ishlab chiquvchisi sifatida imij yaratmoqda va markaziy nerv tizimi (CNS) terapiyasi yondashuvlarini transformatsiya qilmoqda. -0.70 indikatori bilan narx harakati, miya yallig'lanishini bostirishga qodir noyob molekulalarning yaratilishi tufayli biznesning kuchli narx belgilash imkoniyatini tasdiqlaydi.
MetaVia Inc. (MTVA) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi ko'rsatkichlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning xususiy kapitalga nisbati MetaVia Inc|MTVA - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga koeffitsiyenti MetaVia, Inc.|MTVA - Kompaniyaning jamlangan qarzlari|Balans kapitallashuviga qarzlar MetaVia Inc.|MTVA - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli kredit va qarzlari MetaVia|Oraliq qoplama koeffitsiyenti metaviatx.com
- foyda va qiymat multiplikatorlari haqida ma'lumot:
MTVA - Kompaniyaning sof foydasi|Sof foyda prognozi MetaVia Inc|MTVA - P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati MetaVia, Inc.|MTVA - Narxning foydaga va o‘sish sur’atiga nisbati|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati koeffitsiyenti MetaVia Inc.|MTVA - Eskirish chegirilmasdan oldingi operatsion foyda|So'nggi to'rtta chorak uchun bir aksiya uchun foyda MetaVia|MTVA - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sishi metaviatx.com|MTVA - Joriy yilda foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi MetaVia Inc
Kompaniyaning jamlanma tahlili:MTVA, metaviatx.com
MetaVia Inc. kompaniyasining neyrodegenerativ kasalliklar terapiyasi sohasidagi innovatsiyalari yuqori investitsiya jozibadorligini ta'minlamoqda, bu esa kompaniyaning taxminiy P/E koeffitsiyentida aks etgan. Ushbu koeffitsiyent bozor kapitalizatsiyasini sof foyda bilan taqqoslaydi, bu esa investitsiyalarning qoplanish muddatini baholash hamda aktivning uzoq muddatda real pul oqimini yaratish qobiliyatiga nisbatan haddan tashqari qimmat baholanganligi yoki yo'qligini aniqlash imkonini beradi.
Raqobatdosh kompaniyalar
Narx-foyda koeffitsiyenti biogen.com (BIIB)|P/E multiplikatori NBIX|RGC - Kapitalizatsiyaning foydaga nisbati|Axsome Therapeutics Inc - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati ACAD (ACADIA Corp)|Xenon Pharmaceuticals - P/E multiplikatori|VKTX - P/E multiplikatori|SUPN (Supernus) - Narx-foyda koeffitsiyenti|CPRX (Catalyst Pharma) - Narxning foydaga nisbati|DNLI (Denali Therapeutics Inc) - P/E multiplikatori|Harmony Corp (HRMY) - Biznesning o‘zini qoplash muddati|P/E multiplikatori BHVN|P/E multiplikatori amylyx.com (AMLX)|Trevi Therapeutics, Inc. - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati PRAX|Anavex Corp - P/E multiplikatori|Biznesning o‘zini qoplash muddati CeriBell EEG CBLL|prothena.com (PRTA) - Narxning foydaga nisbati|Narx-foyda multiplikatori ALEC|ANNX (Annexon) - P/E multiplikatori|Narx-foyda koeffitsiyenti Omeros Corp. (OMER)|Narxning foydaga nisbati Neurogene Corp (NGNE)|Narx-foyda koeffitsiyenti AC Immune Inc ACIU|Voyager Therapeutics - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati NMRA (neumoratx.com)|SCLX: Narx-foyda koeffitsiyenti|TVGN: Narxning foydaga nisbati|ACOG: P/E multiplikatori|Cognition Therapeutics Inc. (CGTX) - P/E multiplikatori|Narxning foydaga nisbati Inhibikase Therapeutics|Narx-foyda multiplikatori SAVA (cassavasciences.com)|P/E multiplikatori ASRT|COYA - Kapitalizatsiyaning foydaga nisbati|Vistagen - Narx-foyda koeffitsiyenti|P/E multiplikatori Ovid Therapeutics Inc OVID|ABOS - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati CRVO (cervomed.com)|alteritytherapeutics.com (ATHE) - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati Clene (CLNN)|Narxning foydaga nisbati PepGen Inc|Narx-foyda koeffitsiyenti Jupiter Neurosciences, Inc. (JUNS)|P/E multiplikatori RLMD|ANVS - Kapitalizatsiyaning foydaga nisbati|Grace Therapeutics - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati AIFF (Firefly Neuroscience, Inc.)|ANEW Medical, Inc. - P/E multiplikatori|NRSN - P/E multiplikatori|RVPH (Reviva Pharmaceuticals) - Narx-foyda koeffitsiyenti|NRXS (neuraxis.com) - Narxning foydaga nisbati|HSDT (Helius Medical Technologies, Inc.) - P/E multiplikatori|Passage Bio Corp (PASG) - Biznesning o‘zini qoplash muddati|P/E multiplikatori NEUP|P/E multiplikatori Minerva (NERV)|Athira Pharma, Inc. - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati ADXN|Alzamend - P/E multiplikatori|Biznesning o‘zini qoplash muddati Cyclerion Therapeutics CYCN|protagenic.com (PTIX) - Narxning foydaga nisbati|Narx-foyda multiplikatori KTTA|CRGT (Cortigent Inc) - P/E multiplikatori|Narx-foyda koeffitsiyenti avenuetx.com (ATXI)|Narxning foydaga nisbati BrainStorm Cell Therapeutics (BCLI)|Narx-foyda koeffitsiyenti Cara Therapeutics Inc. CARA|Chromocell Therapeutics Corporation - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati ELYM (Eliem Therapeutics, Inc.)|ITCI: Narx-foyda koeffitsiyenti|LBPH: Narxning foydaga nisbati|MRNS: P/E multiplikatori|NKGen Biotech Inc (NKGN) - P/E multiplikatori|Narxning foydaga nisbati NeuroBo|Narx-foyda multiplikatori SAGE (Sage Therapeutics Inc)|P/E multiplikatori SNPX|TRVN - Kapitalizatsiyaning foydaga nisbati|Vigil Neuroscience, Inc. - Narx-foyda koeffitsiyenti|P/E multiplikatori anewmeds.com WENA|CERE - Narxning foydaga nisbati
